Chemed Shares Fall On Earnings Miss, Executive Departure

Dow Jones

2025/07/30

By Nicholas G. Miller

Chemed shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving.

The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months.

The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share.

The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share.

The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1.

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

(END) Dow Jones Newswires

July 29, 2025 17:54 ET (21:54 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2555621700"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555621700\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2555621700?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-30 05:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555621700","market":"fut","top_or_hot":-1,"title":"Chemed Shares Fall On Earnings Miss, Executive Departure","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Nicholas G. <a href=\"https://laohu8.com/S/MLR\">Miller</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/CHE\">Chemed</a> shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving. \n</p>\n<p>\n  The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months. \n</p>\n<p>\n  The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share. \n</p>\n<p>\n  The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share. \n</p>\n<p>\n  The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1. \n</p>\n<p>\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 29, 2025 17:54 ET (21:54 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chemed Shares Fall On Earnings Miss, Executive Departure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChemed Shares Fall On Earnings Miss, Executive Departure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-30 05:54</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Nicholas G. <a href=\"https://laohu8.com/S/MLR\">Miller</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/CHE\">Chemed</a> shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving. \n</p>\n<p>\n  The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months. \n</p>\n<p>\n  The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share. \n</p>\n<p>\n  The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share. \n</p>\n<p>\n  The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1. \n</p>\n<p>\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 29, 2025 17:54 ET (21:54 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CHE","symbol_name":"Chemed Corp","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2555621700","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555621700","pubTimestamp":1753826040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Chemed shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving.The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months.The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share.The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share.The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CHE":"Chemed Corp"},"translate_title":"Chemed股价因盈利未达预期和高管离职而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHE":1},"content_text":"By Nicholas G. Miller\n\n\nChemed shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving. \n\n\n  The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months. \n\n\n  The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share. \n\n\n  The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share. \n\n\n  The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1. \n\n\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 29, 2025 17:54 ET (21:54 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}